NICE and PHE recommend all employers give mental health training for managers

All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.

Read news story

  1. NICE recommends treatment for people with juvenile idiopathic arthritis

    NICE has today (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.

Blogs

NICE Talks podcasts

NICE Talks brings you the real life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 07973 970 534 | pressoffice@nice.org.uk